Publications by authors named "Shmueli Einat"

Aim: Our aim was to examine how fever duration affected the ability of biomarkers to diagnose community-acquired pneumonia (CAP).

Methods: This was a retrospective cohort study of children aged 2-18 years who attended the emergency department at Schneider Children's Medical Centre of Israel with CAP from June 2015 to May 2020. The children underwent biomarker measurements and chest radiographs and optimal biomarker thresholds were identified.

View Article and Find Full Text PDF

During the COVID-19 pandemic wearing face masks was mandatory. Nowadays, face masks are still encouraged indoors, especially in hospitals. People climbing stairs with masks describe unpredictable dyspnea.

View Article and Find Full Text PDF

Background: Pediatric Post-COVID-Condition (PPCC) clinics treat children despite limited scientific substantiation. By exploring real-life management of children diagnosed with PPCC, the International Post-COVID-Condition in Children Collaboration (IP4C) aimed to provide guidance for future PPCC care.

Methods: We performed a cross-sectional international, multicenter study on used PPCC definitions; the organization of PPCC care programs and patients characteristics.

View Article and Find Full Text PDF

Studies on post-COVID-19 condition (PCC) in adults have shown deterioration in pulmonary function tests (PFTs), mainly a diffusion limitation. Among the pediatric population, data are scarce. To characterize PFTs in children with PCC, including changes over time.

View Article and Find Full Text PDF

Background: Lung function deterioration in cystic fibrosis (CF) is typically measured by a decline in the forced expiratory volume in one second (FEV%), which is thought to be a late marker of lung disease. Dynamic hyperinflation (DH) is seen in obstructive lung diseases while exercising. Our aim was to assess whether DH could predict pulmonary deterioration in CF; a secondary measure was the peak VO.

View Article and Find Full Text PDF

Unlabelled: Early childhood dental caries is the most prevalent disease in childhood. Paediatricians are considered by parents as the main authority on prevention and treatment of all the health requirements of their infants.

Aim: The aim of this study was to evaluate the knowledge and practice of paediatricians in promoting oral and dental health among young patients (under age 36 months) and their parents.

View Article and Find Full Text PDF

Several dry-powder inhalers (DPIs) contain lactose which may be contaminated with milk proteins. Confusion exists pertaining to DPI use in patients with cow's milk protein allergy (CMPA). A computerized survey sent via e-mail to pediatric pulmonologists and allergologists.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the effectiveness of the drug combination Elexacaftor/Tezacaftor/Ivacaftor (ETI) in patients with cystic fibrosis (CF) who have mutations other than F508del.
  • Results showed significant improvements in sweat chloride levels, reduced pulmonary exacerbations, and fewer days on antibiotics for patients who hadn't previously used CFTR modulators.
  • The findings suggest that ETI is clinically effective for CF patients with non-F508del mutations, supporting its routine use for these individuals.
View Article and Find Full Text PDF

Background: Patients with interstitial lung disease (ILD) are at high risk of severe COVID-19 infection. Additionally, their anti-inflammatory and antifibrotic treatment may cause immunosuppression. Nevertheless, their ability to mount an adequate immune response to messenger RNA SARS-CoV-2 vaccines was not evaluated.

View Article and Find Full Text PDF

Background And Aim: The BNT162b2 COVID-19 vaccine (Pfizer/BioNTech), given as a two-dose series, 3 weeks apart, elicits a serological response in 84-98% of patients with cancer, even if administered while undergoing anticancer treatments. Herein, we report the impact of a third (booster) dose of BNT162b2, delivered 6 months following the second vaccine dose.

Methods: This pilot study included four patients with cancer who were seronegative after two vaccine doses, and received a third (booster) dose of BNT162b2 at 6 months following the second vaccine dose.

View Article and Find Full Text PDF

Background: Trials of the Pfizer-BioNTech BNT162b2 mRNA vaccine showed 95% efficacy in preventing symptomatic disease; however, the trials excluded immunocompromised patients (ICPs). We aim at analyzing antibody response in ICPs.

Methods: A prospective cohort study was conducted at Sheba Medical Center, Israel, between January and April 2020, in 1274 participants who received the vaccine, including 1002 ICPs and 272 immunocompetent healthcare workers (HCWs).

View Article and Find Full Text PDF

Aim: Patients with cancer are at an increased risk for severe coronavirus disease of 2019, thus data on the safety and efficacy of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines are essential. We conducted this prospective study of patients with cancer vaccinated with BNT162b2 and monitored for antibody response and safety. The aim was to evaluate the rate of seropositivity and define predictors for non-reactive immune response.

View Article and Find Full Text PDF

Systematic data are lacking on pediatric long COVID. This study prospectively assessed 90 children with persistent symptoms who presented to a designated multidisciplinary clinic for long COVID. In nearly 60%, symptoms were associated with functional impairment at 1-7 months after the onset of infection.

View Article and Find Full Text PDF

Background: During the Coronavirus disease 2019 (COVID-19) pandemic, wearing facemasks became obligatory worldwide.

Objectives: The objective of this study was to evaluate the effects of facemasks on gas exchange.

Methods: Healthy adults were assessed at rest and during slow and brisk 5-minute walks, with and without masks.

View Article and Find Full Text PDF
Article Synopsis
  • RSV bronchiolitis is a leading cause of hospitalization in infants, and more infants with chronic diseases are being hospitalized due to fewer premature infants receiving Palivizumab prophylaxis.* -
  • A study analyzed 1124 hospitalizations from 2014-2018, finding that infants with chronic conditions had longer stays in the hospital (4.8 days) and increased rates of admission to the PICU compared to healthy infants (3.7 days).* -
  • The findings suggest that infants with chronic diseases, particularly those with Down's syndrome, face higher risks of severe illness and might benefit from receiving RSV immune prophylaxis.*
View Article and Find Full Text PDF

Introduction: The use of total neoadjuvant therapy (TNT) for locally advanced rectal cancer has been increasing in recent years, but the long-term overall survival characteristics of this approach is currently unknown.

Methods: We performed a retrospective study of patients with clinical stage II/III rectal cancer within the National Cancer Database. Patients who received TNT (defined as chemotherapy, followed by CRT, followed by surgery) were propensity score matched to patients who received adjuvant therapy (defined as CRT, followed by surgery, followed by chemotherapy).

View Article and Find Full Text PDF

Background: Congenital cytomegalovirus (cCMV) infection is an important cause of hearing loss and neurodevelopment delay. While data on vertical transmission and neonatal outcome after singleton pregnancy with cCMV are well established, only scarce reports have addressed cCMV in multiple birth pregnancies. Furthermore, no studies have yet compared the outcome after birth and long-term follow-up of children with cCMV born after a singleton versus multiple pregnancies.

View Article and Find Full Text PDF
Article Synopsis
  • This study assessed the effectiveness of three treatment protocols for bronchiolitis in children under two at a pediatric facility in Israel.
  • A total of 286 children were included, and the treatment differences led to varying lengths of hospital stay and days with low oxygen saturation.
  • The findings indicated that none of the treatment regimens were superior, and the use of nebulized hypertonic saline and adrenaline was linked to longer hospital stays.
View Article and Find Full Text PDF

Purpose: The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer) study has demonstrated 3-year disease-free survival (DFS) and 6-year overall survival (OS) benefit of adjuvant oxaliplatin in stage II to III resected colon cancer. This update presents 10-year OS and OS and DFS by mismatch repair (MMR) status and BRAF mutation.

Methods: Survival actualization after 10-year follow-up was performed in 2,246 patients with resected stage II to III colon cancer.

View Article and Find Full Text PDF

CD24 is expressed in 90% of colorectal adenomas and adenocarcinomas. Colorectal cancer (CRC) can be mostly prevented but average risk population screening by stool testing or colonoscopy faces many hurdles. Blood testing is clinically needed.

View Article and Find Full Text PDF

We examined the rate, clinical impact, and risk factors of cytomegalovirus (CMV) drug resistance in 561 patients who underwent 616 hematopoietic stem cell transplantations (HSCTs) over 5 years. Drug resistance was exclusively identified in haploidentical (haplo)-HSCT recipients receiving preemptive therapy, among whom the rate was 14.5%.

View Article and Find Full Text PDF

During the pandemic (H1N1) 2009 outbreak in Israel, incidence rates among children were 2× higher than that of the previous 4 influenza seasons; hospitalization rates were 5× higher. Children hospitalized for pandemic (H1N1) 2009 were older and had more underlying chronic diseases than those hospitalized for seasonal influenza.

View Article and Find Full Text PDF

Introduction: The accumulated data in recent years on the safety of laparoscopy in colorectal cancer patients encourage more surgeons to use this approach for different colorectal pathologies. However, laparoscopic colorectal surgery consists of different heterogeneous complex procedures that necessitate extensive experience and laparoscopic surgical skills

Purpose: To evaluate safety, levels of difficulty and oncological outcome in a consecutive series of patients that underwent elective laparoscopic colorectal surgery during a 5-year period.

Methods: Evaluation of our prospective collected data of patients that underwent laparoscopic colorectal surgery during a 5-year period by our surgical team.

View Article and Find Full Text PDF